Responses With Asciminib Continue to Deepen Over Time in Patients With Chronic Myeloid Leukemia in Chronic Phase (CML-CP) After 2 Prior Tyrosine Kinase Inhibitors (TKIs) in the Phase III ASCEMBL Study
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA(2023)
关键词
CML,asciminib,TKI,ASCEMBL,phase III
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要